z-logo
open-access-imgOpen Access
Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α
Author(s) -
Rongrong Gao,
Xiaodong Wu,
Huimin Jiang,
Yujiao Zhu,
Yanli Zhou,
Haifeng Zhang,
Wenming Yao,
Yongqin Li,
Xinli Li
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.04.14
Subject(s) - medicine , muscle hypertrophy , peroxisome proliferator activated receptor , cardiac function curve , phenylephrine , endocrinology , coactivator , heart failure , western blot , h&e stain , in vivo , myocardial infarction , receptor , cardiology , transcription factor , chemistry , biology , immunohistochemistry , blood pressure , gene , biochemistry , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom